TRA-1-60 Antibody, anti-human, Vio® 488, REAfinity™, 100 µL
文献支持

TRA-1-60 Antibody, anti-human,

Vio® 488, REAfinity™, 100 µL
收藏
  • 询价
  • Miltenyi Biotec已认证
  • 德国
  • 130-106-872
  • 2025年12月09日
  • Flow cytometry, Immunocytochemistry
  • human cell line
  • human
avatar
品牌商
13钻石会员
  • 企业认证

    • 详细信息
    • 文献和实验
    • 技术资料
    • 免疫原

      TRA-1-60

    • 亚型

      recombinant human IgG1

    • 形态

      Antibodies are supplied in phosphate-buffered saline (PBS), pH 7.2. The product contains no preservative and is sterile filtered. Always handle under aseptic conditions.

    • 保存条件

      避光,2-8℃

    • 克隆性

      REA157

    • 标记物

      Vio 488

    • 适应物种

      human

    • 保质期

      24个月

    • 供应商

      Miltenyi Biotec

    • 宿主

      human cell line

    • 应用范围

      Flow cytometry, Immunocytochemistry

    • 抗体英文名

      TRA-1-60 Antibody, anti-human, REAfinity™

    • 抗体名

      TRA-1-60 Antibody, anti-human, REAfinity™

    • 规格

      100 µL

    Detection of TRA-1-60+ cells in cell cultureClone REA157 recognizes the TRA-1-60 antigen, a neuraminidase-resistant carbohydrate epitope expressed on podocalyxin, which is a transmembrane glycoprotein. Podocalyxin is a member of the CD34-related family of sialomucins and is recognized as a stem cell and tumor marker. TRA-1-60 antigen is expressed on the surface of human embryonic stem cells (ESC), embryonic germ cells (EG), and embryonic carcinoma cells (EC). Expression of TRA-1-60 is lost upon differentiation and thus it can be used to assess the differentiation stage of the cells. TRA-1-60 can be detected in the serum of patients with germ cell tumors which contain an EC component. | Additional information: Clone REA157 displays negligible binding to Fc receptors. |

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    Andrews, P. W. et al. (1984) Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells. Hybridoma 3 (4): 347–361. | Lajer, H. et al. (2002) Clinical use of serum TRA-1-60 as tumor marker in patients with germ cell cancer. Int. J. Cancer 100 (2): 244–246. | Schopperle, W. M. et al. (2007) The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma. Stem Cells 25 (3): 723–730.
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    德国美天旎生物技术有限公司
    2025年12月09日询价
    询价
    上海再康生物科技有限公司
    2025年11月20日询价
    询价
    上海信裕生物科技有限公司
    2025年07月07日询价
    ¥500
    北京百奥创新科技有限公司
    2025年07月11日询价
    ¥2070
    朗智(上海)生物科技有限公司
    2025年08月23日询价
    文献支持
    TRA-1-60 Antibody, anti-human, Vio® 488, REAfinity™, 100 µL
    询价